DEMGY at the Medi'nov trade show: expertise, innovation, and commitment to the medical device industry
DEMGY will be at the Medinov trade show from July 1–2 at booth 57 to showcase its unique expertise in providing comprehensive support to manufacturers in the medical sector. DEMGY is involved in every stage of the process, from the design, implementation, and qualification of processes, through to the production of high-value-added medical devices and pharmaceutical packaging.
With a sustained investment strategy, DEMGY is strengthening its position as a major player in the medical device industry. The Group currently relies on:
- 4 ISO 13485-certified sites,
- ISO 7 & ISO 8 cleanrooms dedicated to injection molding, micro-injection, and assembly,
- expertise in microfluidics, enabling the development of lab-on-a-chip and innovative technological solutions.
This growth demonstrates the Group’s commitment to supporting manufacturers in their most demanding projects by ensuring quality, traceability, and performance.
Flash Conference: July 1 at 9:50 AM
Innovative medical device for the treatment of solid cancers, particularly breast cancer
As part of the CAPDCM project, DEMGY is contributing to the development of a biocompatible device incorporating homogeneous, sealed microchannels that trap metastatic cells.
This cross-functional project brings together expertise in biology, chemistry, microfluidics, and clinical science, demonstrating the Group’s ability to support breakthrough innovations in the fight against cancer.
The conference will be moderated by:
- Jean Marie Ramirez, PhD from the University of Montpellier, specialist in cell biology and tumor microenvironments.
- Jean Claude Sondaz, CEO of DEMGY Frasne, expert in microinjection, microfluidics, and industrialization